1. Embryonal rhabdomyosarcoma of the cervix and appendiceal carcinoid tumor.
- Author
-
Adams BN, Brandt JS, Loukeris K, and Holcomb K
- Subjects
- Adult, Antineoplastic Combined Chemotherapy Protocols, Appendectomy, Appendiceal Neoplasms drug therapy, Appendiceal Neoplasms surgery, Appendix pathology, Appendix surgery, Carcinoid Tumor drug therapy, Carcinoid Tumor surgery, Cervix Uteri pathology, Cervix Uteri surgery, Chemotherapy, Adjuvant, Combined Modality Therapy, Cyclophosphamide therapeutic use, Dactinomycin therapeutic use, Female, Humans, Hysterectomy, Rhabdomyosarcoma, Embryonal drug therapy, Rhabdomyosarcoma, Embryonal surgery, Uterine Cervical Neoplasms drug therapy, Uterine Cervical Neoplasms surgery, Vincristine therapeutic use, Appendiceal Neoplasms diagnosis, Carcinoid Tumor diagnosis, Rhabdomyosarcoma, Embryonal diagnosis, Uterine Cervical Neoplasms diagnosis
- Abstract
Background: Rhabdomyosarcomas, particularly those of gynecologic origin, are very rare in adults. As a result, there is little literature on the optimal staging procedure and treatment modalities for this population., Case: A 43-year-old woman presented with a long-standing history of menorrhagia and was subsequently diagnosed with embryonal rhabdomyosarcoma of the cervix. She underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy, lymph node dissection, omentectomy, and appendectomy, which also revealed a synchronous tubular carcinoid tumor of appendiceal origin. Plans for treatment involve adjuvant chemotherapy with vincristine, dactinomycin, and cyclophosphamide., Conclusion: This case adds to the small body of literature surrounding cervical embryonal rhabdomyosarcoma in women over the age of 40 years and proposes that appendectomy be considered during surgical management.
- Published
- 2011
- Full Text
- View/download PDF